File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The Role of Percutaneous Transluminal Angioplasty in the Treatment of Carotid Fibromuscular Dysplasia

TitleThe Role of Percutaneous Transluminal Angioplasty in the Treatment of Carotid Fibromuscular Dysplasia
Authors
KeywordsFibromuscular dysplasia
Carotid artery stenosis
Percutaneous transluminal angioplasty
Issue Date2003
PublisherElsevier Ltd. The Journal's web site is located at http://ejvesextra.com/
Citation
EJVES Extra, 2003, v. 5 n. 6, p. 102-105 How to Cite?
AbstractFibromuscular dysplasia (FMD) is a disease of unknown aetiology, first typically presenting in the medium and large arteries of young to middle-aged women. It was first described by Leadbetter and Burkland in 1938 and is most commonly noted to involve the renal vessels. The management of FMD with severely stenotic and symptomatic lesions has historically been surgical. It has been shown previously that percutaneous transluminal angioplasty (PTA) works well in the setting of renal artery FMD. We report a case where PTA was used in the treatment of a patient with severe symptomatic internal carotid FMD. The results in this case appear to suggest that angioplasty can be used as a treatment for internal carotid FMD with good clinical resolution of symptoms. Further studies are required to assess efficacy, durability, and complication rates.
Persistent Identifierhttp://hdl.handle.net/10722/195834
ISSN
2015 SCImago Journal Rankings: 0.105

 

DC FieldValueLanguage
dc.contributor.authorHui, KMC-
dc.contributor.authorBaker, D-
dc.contributor.authorPlatts, A-
dc.date.accessioned2014-03-13T09:05:37Z-
dc.date.available2014-03-13T09:05:37Z-
dc.date.issued2003-
dc.identifier.citationEJVES Extra, 2003, v. 5 n. 6, p. 102-105-
dc.identifier.issn1533-3167-
dc.identifier.urihttp://hdl.handle.net/10722/195834-
dc.description.abstractFibromuscular dysplasia (FMD) is a disease of unknown aetiology, first typically presenting in the medium and large arteries of young to middle-aged women. It was first described by Leadbetter and Burkland in 1938 and is most commonly noted to involve the renal vessels. The management of FMD with severely stenotic and symptomatic lesions has historically been surgical. It has been shown previously that percutaneous transluminal angioplasty (PTA) works well in the setting of renal artery FMD. We report a case where PTA was used in the treatment of a patient with severe symptomatic internal carotid FMD. The results in this case appear to suggest that angioplasty can be used as a treatment for internal carotid FMD with good clinical resolution of symptoms. Further studies are required to assess efficacy, durability, and complication rates.-
dc.languageeng-
dc.publisherElsevier Ltd. The Journal's web site is located at http://ejvesextra.com/-
dc.relation.ispartofEJVES Extra-
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in EJVES Extra. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in EJVES Extra, [VOL 5, ISSUE 6, 2003] DOI 10.1016/S1533-3167(03)00040-2-
dc.subjectFibromuscular dysplasia-
dc.subjectCarotid artery stenosis-
dc.subjectPercutaneous transluminal angioplasty-
dc.titleThe Role of Percutaneous Transluminal Angioplasty in the Treatment of Carotid Fibromuscular Dysplasiaen_US
dc.typeArticleen_US
dc.identifier.emailHui, KMC: chris.hui@hku.hk-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S1533-3167(03)00040-2-
dc.identifier.volume5-
dc.identifier.issue6-
dc.identifier.spage102-
dc.identifier.epage105-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats